Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-14 · accession 0001517026-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | 2024-04-14 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $19.55 | -1,076 | 298.7K | -0.4% | -$21.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-14 | F | D | 1,076 | $19.55 | 298,715 | D | — | — |